Avacta to launch SARS-CoV-2 ELISA laboratory test
Following successful evaluation by The Liverpool School of Tropical Medicine, the ELISA test will now be made available for COVID-19 researchers
Following successful evaluation by The Liverpool School of Tropical Medicine, the ELISA test will now be made available for COVID-19 researchers
Read this application note to discover how T cell activation assays can help accelerate COVID-19 vaccine development
Watch this on-demand webinar to find out how Aerospray technology could elevate your lab’s performance
Rapid increase in production of VTM and saline will help boost virus testing
Watch this on-demand webinar to learn about the latest approaches in single nucleus transcriptomics and ATAC-Seq
Join us to learn how to perform untargeted/semi-targeted metabolomic studies to discover novel biomarkers by mass spectrometry
Ready-to-use kit enables rapid adeno-associated virus (AAV) titer determinations during the manufacture of AAV vectors
Meet the researchers making waves in science and learn about the technologies innovating their research
Avacta and Liverpool School of Tropical Medicine collaborate to clinically validate saliva-based rapid coronavirus test being developed with Cytiva
Test delivers results in just 15 minutes with no instrumentation, using proven lateral flow technology with demonstrated sensitivity of 97.1% and specificity of 98.5%
First participants dosed in trial of AZD7442 to assess safety, tolerability and pharmacokinetics of the combination
The Thermo Scientific Smart-Vue Pro Remote Monitoring Solution protects samples, improves laboratory efficiency and facilitates regulatory compliance
Workflow is quick, simple and scalable for high-throughput antibody detection with high PPA sensitivity and NPA specificity